Updated on 14 September 2026
NAM Evidence, Regulatory Science and Translational Strategy
Managing Director at FRESCI by SCIENCE&STRATEGY SL
Terrassa, Spain
About
FRESCI (see https://www.fre-sci.com/projects) helps organisations assess biomedical evidence and translate it into clear scientific, regulatory and commercial strategies.
FRESCI-affiliated experts contributed to European Commission JRC reviews covering breast cancer, immuno-oncology, autoimmune diseases and advanced-therapy immunogenicity. Our expertise also includes peer-reviewed work on assessing preclinical translational evidence.
We support context-of-use definition, evidence-gap analysis, interpretation of regulatory expectations and stakeholder communication. Our contribution is to make the strengths, limitations and next development steps of a methodology understandable and actionable.
Attached files
Organisation
Similar opportunities
Service
NAM and MedTech Strategy, Biomedical Business Support and Project Delivery
- Other
- Marketing
- Consulting
- Technology Transfer
- Innovation management
- Research & Development
- Supply chain management
- Education, Training & Qualifying
Marco Straccia
Managing Director at FRESCI by SCIENCE&STRATEGY SL
Terrassa, Spain
Product
Biomedical Knowledge Platforms and AI-Assisted Databases
- Buyer
- License partner
- Re-Seller/Wholesaler
Marco Straccia
Managing Director at FRESCI by SCIENCE&STRATEGY SL
Terrassa, Spain
Investment
MetaTool: Strategic Investment in Pharma Evidence Intelligence
- Pre-seed funding | Idea validation
Marco Straccia
Managing Director at FRESCI by SCIENCE&STRATEGY SL
Terrassa, Spain